| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 00:23:09 UTC |
|---|
| Update Date | 2021-09-26 22:57:02 UTC |
|---|
| HMDB ID | HMDB0247379 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine |
|---|
| Description | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine, also known as 2,3-epoxysuccinyl-L-leucylamido-3-methylbutane or e 64-c, belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Based on a literature review very few articles have been published on N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC(C)CCNC(=O)C(CC(C)C)NC(=O)C1OC1C(O)=O InChI=1S/C15H26N2O5/c1-8(2)5-6-16-13(18)10(7-9(3)4)17-14(19)11-12(22-11)15(20)21/h8-12H,5-7H2,1-4H3,(H,16,18)(H,17,19)(H,20,21) |
|---|
| Synonyms | | Value | Source |
|---|
| 3-({3-methyl-1-[(3-methylbutyl)-C-hydroxycarbonimidoyl]butyl}-C-hydroxycarbonimidoyl)oxirane-2-carboxylate | HMDB | | 2,3-Epoxysuccinyl-L-leucylamido-3-methylbutane | HMDB | | e 64-c | HMDB | | e 64C | HMDB | | e-64-c | HMDB | | e-64C | HMDB | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine, monosodium salt | HMDB | | N-(N-(3-Transcarboxyoxirane-2-carbonyl)-L-leucyl)-3-methylbutylamine | HMDB | | N-(N-(L-3-trans-Carboxyoxirane -2-carbonyl)-L-leucyl)isoamylamine | HMDB |
|
|---|
| Chemical Formula | C15H26N2O5 |
|---|
| Average Molecular Weight | 314.382 |
|---|
| Monoisotopic Molecular Weight | 314.184171945 |
|---|
| IUPAC Name | 3-({3-methyl-1-[(3-methylbutyl)carbamoyl]butyl}carbamoyl)oxirane-2-carboxylic acid |
|---|
| Traditional Name | 3-({3-methyl-1-[(3-methylbutyl)carbamoyl]butyl}carbamoyl)oxirane-2-carboxylic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)CCNC(=O)C(CC(C)C)NC(=O)C1OC1C(O)=O |
|---|
| InChI Identifier | InChI=1S/C15H26N2O5/c1-8(2)5-6-16-13(18)10(7-9(3)4)17-14(19)11-12(22-11)15(20)21/h8-12H,5-7H2,1-4H3,(H,16,18)(H,17,19)(H,20,21) |
|---|
| InChI Key | SCMSYZJDIQPSDI-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Leucine and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Leucine or derivatives
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Fatty amide
- N-acyl-amine
- Oxirane carboxylic acid
- Fatty acyl
- Oxirane carboxylic acid or derivatives
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid
- Dialkyl ether
- Oxirane
- Ether
- Monocarboxylic acid or derivatives
- Oxacycle
- Organoheterocyclic compound
- Organopnictogen compound
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Organic nitrogen compound
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 13.7959 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.56 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2377.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 285.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 154.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 161.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 110.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 539.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 620.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 72.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1024.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 494.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1659.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 304.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 391.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 206.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 138.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2343.4 | Semi standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2320.6 | Standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2866.6 | Standard polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TMS,isomer #2 | CC(C)CCNC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2275.2 | Semi standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TMS,isomer #2 | CC(C)CCNC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2306.9 | Standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TMS,isomer #2 | CC(C)CCNC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2816.2 | Standard polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TMS,isomer #3 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O)[Si](C)(C)C)[Si](C)(C)C | 2332.2 | Semi standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TMS,isomer #3 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O)[Si](C)(C)C)[Si](C)(C)C | 2313.1 | Standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TMS,isomer #3 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O)[Si](C)(C)C)[Si](C)(C)C | 2954.9 | Standard polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,3TMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2301.8 | Semi standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,3TMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2407.5 | Standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,3TMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2583.8 | Standard polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TBDMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2807.3 | Semi standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TBDMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2674.6 | Standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TBDMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3036.6 | Standard polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TBDMS,isomer #2 | CC(C)CCNC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2764.2 | Semi standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TBDMS,isomer #2 | CC(C)CCNC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2669.1 | Standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TBDMS,isomer #2 | CC(C)CCNC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2992.9 | Standard polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TBDMS,isomer #3 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2824.2 | Semi standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TBDMS,isomer #3 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2674.0 | Standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,2TBDMS,isomer #3 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3104.5 | Standard polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,3TBDMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3011.9 | Semi standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,3TBDMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2944.8 | Standard non polar | 33892256 | | N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine,3TBDMS,isomer #1 | CC(C)CCN(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2924.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udl-6590000000-47512e5661b9946c6969 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine 10V, Positive-QTOF | splash10-014i-4049000000-c693bd68a4b802cb4653 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine 20V, Positive-QTOF | splash10-01w0-9421000000-0cf7bb618b22403891da | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine 40V, Positive-QTOF | splash10-00kf-9100000000-a3dec8ff67745908cffc | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine 10V, Negative-QTOF | splash10-02ai-5936000000-56582e3dcfc992030e9e | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine 20V, Negative-QTOF | splash10-001r-7900000000-4e382e5009911772fc87 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-(N-(3-Carboxyoxirane-2-carbonyl)leucyl)isoamylamine 40V, Negative-QTOF | splash10-0006-9200000000-af6940bf9b6c1d06d991 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|